Generic Name and Formulations:
Acyclovir 5% + hydrocortisone 1%; crm.
Valeant Pharmaceuticals, Inc
Indications for XERESE:
Early treatment of recurrent herpes labialis (cold sores), to reduce likelihood of ulcerative cold sores and shorten lesion healing time in adults and adolescents (≥12yrs old).
Start as soon as possible after the first signs/symptoms emerge (ie, during the prodrome or when lesions appear). Wash and dry area. Apply topically to affected area on lips or around the mouth 5 times daily for 5 days. Avoid unnecessary rubbing of affected area to avoid aggravating or transferring infection. Do not occlude. Wash hands before and after application; wait at least 30 minutes before bathing, showering, or swimming.
Immunocompromised. Reevaluate if symptoms persist more than 2 weeks. Avoid eyes, inside the mouth or nose, or on the genitals. Pregnancy (Cat. B). Nursing mothers.
Antiviral + antiinflammatory.
Do not apply other products (makeup, sunscreen, lip balm, etc) to area during treatment.
Drying, flaking, burning/tingling sensation, erythema, pigmentation changes.
Clinical Pain Advisor Articles
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Predictors of Opioid Overdose in High-Risk Users
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Higher PainDETECT Scores, Neuropathic Pain Preoperatively May Increase Risk for Chronic Pain Post-TKR
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Erenumab Reduces Monthly Migraine Days in Patients With Treatment-Resistant Migraine
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- Communication-Based Intervention Increases Goals-of-Care Discussions Between Physicians, Patients With Serious Illness